Big effect
Kefir slashed HOMA-IR by 1.71 points in a meta-analysis — but the same review found no effect on weight, waist size, cholesterol, or inflammation.
This is a large, statistically significant drop in a key marker of insulin resistance, but it comes from only three studies, and the fact that kefir didn't budge any other metabolic or inflammatory measure means the benefit appears narrow — and may not translate into the broader health improvements you'd expect.
HOMA-IR is a score that estimates how resistant your cells are to insulin; a drop of 1.71 is substantial (think of it as moving from prediabetic range toward normal). However, the same analysis found kefir had no effect on body weight, BMI, waist circumference, cholesterol, triglycerides, or inflammatory markers — so while it may improve how your body handles blood sugar, it's not a metabolic cure-all.
Where this fits in the evidence
Pillser has synthesized 3 studies on Kefir for Reduced HOMA-IR — overall evidence strength: Moderate.
Across 3 studies, all reported beneficial effects on HOMA-IR, with effect sizes ranging from small to large. Two meta-analyses found large reductions (WMD -2.56, 95% CI -3.82 to -1.30; MD -1.71), while one RCT in metabolic syndrome patients found a small reduction that was not significantly different from an unfermented milk control. Median study duration was 84 days, but dose data are limited (only one study reported 180 mL/day). Evidence is preliminary and subject to publication bias.
The study
- Meta-Analysis
- 2026-05
- Nutrition, metabolism, and cardiovascular diseases : NMCD
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.